Meta Growth is Canada’s Largest Recreational Pot Stock

Meta Growth

Rich loves bringing new and upcoming pot stocks to the attention of his community. Today, he profiles Meta Growth Corp. (TSXV:META) (OTCPK:NACNF), an Ontario-based cannabis retailer with a powerful claim to fame.

According to the company’s recent press release, Meta is Canada’s “largest publicly traded recreational cannabis retailer by revenue.” This is a tremendous accomplishment for such a relatively unknown cannabis company. As Rich notes, Meta Growth is—in all likelihood—seriously undervalued at its current price.

“Meta was at $1.00 in April, and now it’s at $0.18. That’s despite the fact that this company keeps getting better and better,” he says. “That more than 400% upside from these prices. And I’m going to show you why you should like this company.”

Meta Growth’s Focus on Recreational Cannabis

Until recently, Meta was known as National Access Cannabis. The name change—which aligns the company’s corporate and retail brands, as well as its META ticker—reflects its intention to become “the preeminent cannabis retailer in Canada.”

As part of its re-branding, Meta sold its portfolio of medical pot clinics. This not only allows it to focus on its recreational portfolio, it also generated $4 million in cash. These funds will be used to fund the build-out of Meta’s recreational retail locations.

Enter Your E-mail Address To Subscribe

* indicates required

Meta Growth CEO Mark Goliger said:

“As the industry has evolved, our focus has shifted from medicinal to recreational [pot], and today, retail is our portfolio and our future. Brand recognition and consistency are key to our success and Meta is ready to continue to maintain our leadership position in the Canadian retail market.”

Divesting from medicinal cannabis to better focus on recreational marijuana is a wise choice. Canadians will reportedly spend $5.2 billion on cannabis by the year 2024. Of that amount, 92%—or roughly $4.8 billion—will go towards the recreational sector.

Meta Growth’s Leading Retail Revenue

In the first year since legalization, Meta raised over $60 million in retail sales at a cumulative gross margin of 32%. Ultimately, the company’s adjusted EBITDA came out to $2.3 million.

Nearly $17 million of that revenue was made in Q3 2019. According to New Cannabis Ventures, that represents year-over-year growth of 3,121%.

Through a combination of its revenue and the funds generated from the sale of its medical portfolio, Meta Growth is expanding its retail footprint across Canada.

The company currently has 35 licensed stores in the country, and plans to have 40 stores operating by the end of 2019. By the end of 2020, it expects to have between 95 and 110 retail locations. The company also has a clear roadmap for improving the average revenue it generates per store. This will, in turn, increase the company’s gross margin.

Currently, Meta is only operating in Alberta, Saskatchewan, and Manitoba. It is currently working on opening dispensaries in BC and Ontario, with more provinces to come.

“I believe with all these locations opening up in 2020, Meta is in a position to get into a positive cash flow situation and to eliminate its debt,” says Rich. “It will build shareholder equity for shareholders who want to get in at these prices.”

What do you think? Is META the right play for recreational cannabis? Let us know your take.

For more of Rich’s cannabis profiles, check out this article about Aurora Cannabis Inc. (TSX:ACB) (NYSE:ACB).

Featured image: DepositPhotos © karnauhov

Please See Disclaimer

If You Liked This Article Click To Share


1) The author of the Article, or members of the author’s immediate household or family, do not own any securities of the companies set forth in this Article. The author determined which companies would be included in this article based on my research and understanding of the sector.

2) The Article was issued on behalf of a third party, Meta Growth Corp. Bitrics Markets Group Inc. and/or Iman Consulting Group has or expects to receive $800 Canadian dollars from Market Jar Media Inc. for the creation and distribution of the video.

3) Statements and opinions expressed are the opinions of the author and not Bitrics Markets Group Inc., its directors or officers. The author is wholly responsible for the validity of the statements. The author was not paid by Bitrics Markets Group Inc. for this Article. Bitrics Markets Group Inc. was not paid by the author to publish or syndicate this Article. The information provided above is for informational purposes only and is not a recommendation to buy or sell any security. Bitrics Markets Group Inc. requires contributing authors to disclose any shareholdings in, or economic relationships with, companies that they write about. Bitrics Markets Group Inc. relies upon the authors to accurately provide this information and Bitrics Markets Group Inc. has no means of verifying its accuracy.

4) The Article does not constitute investment advice. Each reader is encouraged to consult with his or her individual financial professional and any action a reader takes as a result of the information presented here is his or her own responsibility. By opening this page, each reader accepts and agrees to Bitrics Markets Group Inc.’s terms of use and full legal disclaimer as set forth here.. This Article is not a solicitation for investment. Bitrics Markets Group Inc. does not render general or specific investment advice and the information on should not be considered a recommendation to buy or sell any security. Bitrics Markets Group Inc. does not endorse or recommend the business, products, services or securities of any company mentioned on

5) Bitrics Markets Group Inc. and its owners, members, officers, directors, partners and consultants may own shares of the profiled companies, which it may sell at any time, including as soon as it deposits such shares into its trading accounts, during our campaign of the profiled companies stock, after our campaign or at any other time. We also may buy and sell securities in the profiled companies which may cause (a) decline in the price of the profiled companies stock due to our selling activities, (b) increased volatility due to our buying and selling of the profiled companies stock and (c) permit us to make substantial profits while we are profiling each of these companies, yet may result in a diminished value to the stock for investors. for any company mentioned in the Article.